| Q4 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-02-23 | ||||||
| REV | |||||||
| Q3 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.200 | -0.210 | -0.0100 | ||||
| REV | 1.460M | 266.000K | -1.194M |
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of ATAI Life Sciences (NASDAQ: ATAI) through any online brokerage.
There are no as such competitors for ATAI Life Sciences.
The latest price target for ATAI Life Sciences (NASDAQ: ATAI) was reported by Maxim Group on November 30, 2021. The analyst firm set a price target for 25.00 expecting ATAI to rise to within 12 months (a possible 406.07% upside). 18 analyst firms have reported ratings in the last year.
The stock price for ATAI Life Sciences (NASDAQ: ATAI) is $4.94 last updated Fri Jan 28 2022 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for ATAI Life Sciences.
ATAI Life Sciences’s $Q4 earnings are confirmed for after-market on February 23, 2022.
There is no upcoming split for ATAI Life Sciences.
ATAI Life Sciences is in the sector and industry. They are listed on the NASDAQ.